首页> 外文期刊>Evidence-based ophthalmology >EXPLORATORY ANALYSIS OF DIABETIC RETINOPATHY PROGRESSION THROUGH 3 YEARS IN A RANDOMIZED CLINICAL TRIAL THAT COMPARES INTRAVITREAL TRIAMCINOLONE ACETONIDE WITH FOCAL/GRID PHOTOCOAGULATION
【24h】

EXPLORATORY ANALYSIS OF DIABETIC RETINOPATHY PROGRESSION THROUGH 3 YEARS IN A RANDOMIZED CLINICAL TRIAL THAT COMPARES INTRAVITREAL TRIAMCINOLONE ACETONIDE WITH FOCAL/GRID PHOTOCOAGULATION

机译:随机性临床试验将糖尿病性视网膜病变进展3年的研究分析,该试验将玻璃体内的曲安奈德与乙酰胺/局部光凝法比较

获取原文
获取原文并翻译 | 示例
       

摘要

Research Objective To analyze the effect of intravitreal triam-cinolone acetonide with focal/grid photo-coagulation on the progression of diabetic retinopathy. Study Design Randomized clinical trial. Location Multiple center in the United States. Funding Source National Eye Institute and the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, United States Department of Health and Human Services: Allergan Inc. Relevant Methodology The participants with diabetic macular edema were randomly assigned to receive laser therapy or intravitreal triamcinolone acetonide (1 or 4mg). Fundus photographs were obtained at the baseline and one, two, and three years.
机译:研究目的分析玻璃体内曲安奈德联合焦/格栅光凝对糖尿病性视网膜病变进展的影响。研究设计随机临床试验。位置美国的多个中心。资金来源美国国立卫生研究院和美国国立卫生研究院,美国国立卫生研究院,美国国立卫生研究院,美国国立眼科研究所,美国糖尿病与消化,肾脏疾病研究所,美国艾尔根公司。玻璃体内曲安奈德(1或4mg)。在基线以及一年,两年和三年时获得眼底照片。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号